- Home
- AARD vs TAVI Comparison
AARD vs TAVI Comparison
Compare AARD & TAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- TAVI
- Stock Information
- Founded
- AARD 2017
- TAVI 2024
- Country
- AARD United States
- TAVI United States
- Employees
- AARD N/A
- TAVI N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- TAVI
- Sector
- AARD Health Care
- TAVI
- Exchange
- AARD Nasdaq
- TAVI Nasdaq
- Market Cap
- AARD 154.9M
- TAVI 160.8M
- IPO Year
- AARD 2025
- TAVI 2024
- Fundamental
- Price
- AARD $10.14
- TAVI $10.14
- Analyst Decision
- AARD Strong Buy
- TAVI
- Analyst Count
- AARD 4
- TAVI 0
- Target Price
- AARD $31.50
- TAVI N/A
- AVG Volume (30 Days)
- AARD 69.4K
- TAVI 6.5K
- Earning Date
- AARD 01-01-0001
- TAVI 01-01-0001
- Dividend Yield
- AARD N/A
- TAVI N/A
- EPS Growth
- AARD N/A
- TAVI N/A
- EPS
- AARD N/A
- TAVI 0.01
- Revenue
- AARD N/A
- TAVI N/A
- Revenue This Year
- AARD N/A
- TAVI N/A
- Revenue Next Year
- AARD N/A
- TAVI N/A
- P/E Ratio
- AARD N/A
- TAVI $2,030.20
- Revenue Growth
- AARD N/A
- TAVI N/A
- 52 Week Low
- AARD $4.88
- TAVI $9.89
- 52 Week High
- AARD $19.58
- TAVI $10.35
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- TAVI N/A
- Support Level
- AARD N/A
- TAVI N/A
- Resistance Level
- AARD N/A
- TAVI N/A
- Average True Range (ATR)
- AARD 0.00
- TAVI 0.00
- MACD
- AARD 0.00
- TAVI 0.00
- Stochastic Oscillator
- AARD 0.00
- TAVI 0.00
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About TAVI Tavia Acquisition Corp. Ordinary Shares
Tavia Acquisition Corp is a blank check company.